beta-Fuoxymorphamine

*beta*-Fuoxymorphamine
Names
	IUPAC name Methyl (2E)-4-{[(5α,6β)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-6-yl]amino}-4-oxo-2-butenoate
Identifiers
3D model (JSmol)	Interactive image;
Abbreviations	β-FOA
ChEMBL	ChEMBL413090;
ChemSpider	8915841;
PubChem CID	44276202;
	InChI InChI=1S/C22H26N2O6/c1-24-10-9-21-18-12-3-4-14(25)19(18)30-20(21)13(7-8-22(21,28)15(24)11-12)23-16(26)5-6-17(27)29-2/h3-6,13,15,20,25,28H,7-11H2,1-2H3,(H,23,26)/b6-5+/t13-,15-,20+,21+,22-/m1/s1 Key: VYGVQURMYFVOPO-IRYZUVSXSA-N;
	SMILES O=C(OC)\C=C\C(=O)N[C@H]4[C@@H]5Oc1c2c(ccc1O)C[C@H]3N(CC[C@]25[C@@]3(O)CC4)C;
Properties
Chemical formula	C22H26N2O6
Molar mass	414.458 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

beta-Fuoxymorphamine (β-fuoxymorphamine) is an opioid acting at μ-opioid receptors. It is used experimentally.^[1]^[2]

References[edit]

^ Portoghese PS, Takemori AE (October 1983). "Different receptor sites mediate opioid agonism and antagonism". Journal of Medicinal Chemistry. 26 (10): 1341–3. doi:10.1021/jm00364a001. PMID 6312042.
^ Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, et al. (August 2015). "Structural insights into µ-opioid receptor activation". Nature. 524 (7565): 315–21. Bibcode:2015Natur.524..315H. doi:10.1038/nature14886. PMC 4639397. PMID 26245379.

This analgesic-related article is a stub. You can help Wikipedia by expanding it.